Skip to: Curated Story Group 1
Visually Open Nav.
Advertise
with us
US
EUROPE
APAC
CANADA
LATAM
subscribe
Open Search Field.
Home
Topics
Biomanufacturing
Biomanufacturing
Biomanufacturing
Biomanufacturing
Biomanufacturing
Business Services
Business Services
Business Services
Business Services
Business Services
Drug Discovery
Drug Discovery
Drug Discovery
Drug Discovery
Drug Discovery
Pharmacy Management
Regulatory Services
CXO Insights
Vendor Viewpoint
News
Conferences
Newsletter
Whitepapers
Magazine
CXO Awards
DECEMBER 2023LIFE SCIENCES REVIEW6The integration of cutting-edge technology in clinical laboratory services represents a paradigm shift in healthcare delivery. From automation and artificial intelligence to telepathology and big data analytics, these innovations are streamlining processes, improving accuracy, and ultimately enhancing patient outcomes. According to Grand View Research, the estimated size of the global clinical laboratory service market was USD 217.53 billion in 2022, and it is projected to experience a compound annual growth rate (CAGR) of 3.2 percent from 2023 to 2030. The industry is undergoing significant expansion, driven by factors such as the rising burden of chronic diseases and an escalating demand for early diagnostic tests.Automation is one of the key elements transforming clinical laboratories. Automated analyzers and robotic systems have significantly improved the speed and precision of diagnostic tests. AI and ML technologies can quickly identify patterns, outliers, and subtle nuances that might escape the human eye. The utilization of big data in clinical laboratories is yet another milestone. Laboratories can gain valuable insights into disease trends, treatment outcomes, and potential areas for medical research by aggregating and analyzing vast amounts of data from varied sources.In this edition of Life Sciences Review APAC, we showcase insights into the latest trends and developments in clinical laboratory services and how healthcare facilities leverage the upcoming technologies to offer safe and accurate diagnostic results. Esteemed industry experts Danielle Portnik, Regional Business Director, Ambry Genetics, IngunaAdovica, Head of Clinical Research Quality Division at JSC Olainfarm, and Vadimssis, Head of Medicine and Clinical Research Department at JSC Olainfarm, share their perspectives.We hope this edition of Life Sciences Review APAC will assist you in finding the right partner suitable to your business requirements.Let us know your thoughts!EDITORIALUnveiling the Tech Renaissance in Clinical Laboratory ServicesCopyright © 2023 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasGilbert HooverAncel CastelinoDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsDecember - 08 - 2023, Vol 04, Issue - 59 ( ISSN 2831-8331) Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com VisualizersHenry SmithVictor Cruz Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com
<
Page 5
|
Page 7
>